NO993435D0 - Transdermal acetylsalicylic acid containing therapeutic system with enhanced resorption - Google Patents

Transdermal acetylsalicylic acid containing therapeutic system with enhanced resorption

Info

Publication number
NO993435D0
NO993435D0 NO993435A NO993435A NO993435D0 NO 993435 D0 NO993435 D0 NO 993435D0 NO 993435 A NO993435 A NO 993435A NO 993435 A NO993435 A NO 993435A NO 993435 D0 NO993435 D0 NO 993435D0
Authority
NO
Norway
Prior art keywords
transdermal
acid containing
acetylsalicylic acid
therapeutic system
containing therapeutic
Prior art date
Application number
NO993435A
Other languages
Norwegian (no)
Other versions
NO993435L (en
Inventor
Michael Horstmann
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO993435D0 publication Critical patent/NO993435D0/en
Publication of NO993435L publication Critical patent/NO993435L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO993435A 1997-01-15 1999-07-12 Transdermal acetylsalicylic acid containing therapeutic system with enhanced resorption NO993435L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19701059A DE19701059C2 (en) 1997-01-15 1997-01-15 Transdermal therapeutic system with absorption enhancement containing acetylsalicylic acid
PCT/EP1998/000013 WO1998031348A1 (en) 1997-01-15 1998-01-03 Transdermal, acetylsalicylic acid-containing therapeutic system with reinforced resorption

Publications (2)

Publication Number Publication Date
NO993435D0 true NO993435D0 (en) 1999-07-12
NO993435L NO993435L (en) 1999-07-12

Family

ID=7817375

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993435A NO993435L (en) 1997-01-15 1999-07-12 Transdermal acetylsalicylic acid containing therapeutic system with enhanced resorption

Country Status (8)

Country Link
EP (1) EP1023053A1 (en)
JP (1) JP2001508069A (en)
KR (1) KR20000070228A (en)
AU (1) AU726094B2 (en)
CA (1) CA2277366A1 (en)
DE (1) DE19701059C2 (en)
NO (1) NO993435L (en)
WO (1) WO1998031348A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19949202A1 (en) * 1999-10-13 2001-05-03 Lohmann Therapie Syst Lts Transdermal therapeutic system for the delivery of acetylsalicylic acid and / or salicylic acid
DE19949252B4 (en) * 1999-10-13 2004-02-12 Lts Lohmann Therapie-Systeme Ag Use of a superficial therapeutic system for the topical application of acetylsalicylic acid for the treatment of acne disorders and process for its preparation
DE19959913A1 (en) * 1999-12-11 2001-06-28 Lohmann Therapie Syst Lts Transdermal system for the treatment of migraines containing acetylsalicylic acid
KR100448469B1 (en) * 2001-10-26 2004-09-13 신풍제약주식회사 Transdermal composition and device of anti-inflammatory agents
EP1446104B2 (en) 2001-11-01 2011-08-03 Novartis AG Spray drying methods
DE10338162B3 (en) † 2003-08-20 2005-06-02 Haldex Brake Products Gmbh Method for operating a compressed air procurement system of a motor vehicle and compressed air treatment device
DE102005033543A1 (en) * 2005-07-14 2007-01-18 Grünenthal GmbH A fragrance-containing transdermal therapeutic system
DE102005050431A1 (en) * 2005-10-21 2007-04-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the administration of lipophilic and / or less skin-permeable active ingredients
IT202000014578A1 (en) * 2020-06-18 2021-12-18 Poli Md S R L MEDICAL DEVICE INCLUDING ACETYL SALICYLIC ACID

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
US5164416A (en) * 1989-02-03 1992-11-17 Lintec Corporation Transdermal therapeutic formulation containing a limonene
DE4332094C2 (en) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Active substance plaster which can be produced without solvent and process for its preparation
DE4332093C2 (en) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermal therapeutic system with the active ingredient acetylsalicylic acid and process for its preparation

Also Published As

Publication number Publication date
DE19701059A1 (en) 1998-07-16
AU726094B2 (en) 2000-11-02
AU5986298A (en) 1998-08-07
KR20000070228A (en) 2000-11-25
DE19701059C2 (en) 2000-12-21
JP2001508069A (en) 2001-06-19
EP1023053A1 (en) 2000-08-02
WO1998031348A1 (en) 1998-07-23
NO993435L (en) 1999-07-12
CA2277366A1 (en) 1998-07-23

Similar Documents

Publication Publication Date Title
ID24118A (en) COMBINED THERAPY
DE69833854D1 (en) THERAPEUTIC ULTRASOUND SYSTEM
FI973002A (en) Therapeutic compound - fatty acid conjugate
DE69832055D1 (en) TRANSDERMAL DELIVERY SYSTEM
DE59813222D1 (en) CATHETER SYSTEM
ID22878A (en) ACTIVE COMPOSITION THERAPY
DE69841826D1 (en) IMMUNITY-STRUCTURING MILKY ACID BACTERIA
DE69825987D1 (en) CATHETER SYSTEM
ATE248812T1 (en) ARYLSULFONYLHYDROXAMIC ACID DERIVATIVES
IS5425A (en) Medicament
DK0769017T3 (en) Therapeutic compounds
ID24275A (en) COMBINATION THERAPY
DE59810166D1 (en) ANALGESIC COMBINATION
DK1017392T3 (en) Medicines
DE59500266D1 (en) Transdermal therapeutic system for the application of naloxone
DE69606053D1 (en) MODIFIED FLUORSULFONIC ACID
DE59402189D1 (en) 2-keto-3-methyl-4-hydroxy-valeric acid
PT878467E (en) 6-AMINOTETRAHYDROISOQUINOLINACARBOXYLIC ACID AND SUBSTITUTED 7-AMINOTETHYDROISOQUINOLINACARBOXYLS
NO993435D0 (en) Transdermal acetylsalicylic acid containing therapeutic system with enhanced resorption
AU7660900A (en) Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid
NO993855D0 (en) Flexible transdermal therapeutic system
NO20001835D0 (en) WOF inhibitor
DE69823908D1 (en) single crystal
ID17052A (en) THERAPEUTIC ACID ACID DRIVINGS
ID24413A (en) BIFENIL DRIVINGS AS MEDICINES

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application